Fox Run Management, L.L.C. Collegium Pharmaceutical, Inc Transaction History

Fox Run Management, L.L.C.

  • $433 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$31.23 - $40.91 $168,673 - $220,954
5,401 New
5,401 $209,000
Q2 2018

Jul 17, 2018
SELL
$21.79 - $28.29 $188,134 - $244,255
-8,634 Closed
0 $0
Q1 2018

Apr 17, 2018
BUY
$18.15 - $29.21 $156,707 - $252,199
8,634 New
8,634 $221,000

Others Institutions Holding COLL

# of Institutions
249
Shares Held
36.2M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email